AU2001253323A1 - Extracellular matrix polynucleotides, polypeptides, and antibodies - Google Patents

Extracellular matrix polynucleotides, polypeptides, and antibodies

Info

Publication number
AU2001253323A1
AU2001253323A1 AU2001253323A AU5332301A AU2001253323A1 AU 2001253323 A1 AU2001253323 A1 AU 2001253323A1 AU 2001253323 A AU2001253323 A AU 2001253323A AU 5332301 A AU5332301 A AU 5332301A AU 2001253323 A1 AU2001253323 A1 AU 2001253323A1
Authority
AU
Australia
Prior art keywords
polypeptides
antibodies
extracellular matrix
polynucleotides
matrix polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253323A
Other languages
English (en)
Inventor
Reinhard Ebner
Michele Fiscella
Steven M Ruben
Yanggu Shi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2001253323A1 publication Critical patent/AU2001253323A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001253323A 2000-04-18 2001-04-11 Extracellular matrix polynucleotides, polypeptides, and antibodies Abandoned AU2001253323A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19812300P 2000-04-18 2000-04-18
US60198123 2000-04-18
PCT/US2001/011643 WO2001079253A1 (fr) 2000-04-18 2001-04-11 Polynucleotides, polypeptides et anticorps matriciels extracellulaires

Publications (1)

Publication Number Publication Date
AU2001253323A1 true AU2001253323A1 (en) 2001-10-30

Family

ID=22732073

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253323A Abandoned AU2001253323A1 (en) 2000-04-18 2001-04-11 Extracellular matrix polynucleotides, polypeptides, and antibodies

Country Status (6)

Country Link
US (1) US20020106780A1 (fr)
EP (1) EP1287015A1 (fr)
JP (1) JP2004504011A (fr)
AU (1) AU2001253323A1 (fr)
CA (1) CA2403508A1 (fr)
WO (1) WO2001079253A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1240313B1 (fr) * 1999-12-22 2006-07-26 Ucb, S.A. Enzymes homologues de l'heparanase humaine et variants d'epissage
EP1276862A2 (fr) * 2000-04-20 2003-01-22 Pharmacia & Upjohn Company Heparanase ii, un nouveau paralogue humain de l'heparanase
WO2002004645A2 (fr) * 2000-07-12 2002-01-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Deuxieme heparanase humaine et ses variantes epissees a expression predominante dans les muscles du squelette, du coeur et du pancreas
WO2002024718A1 (fr) * 2000-09-19 2002-03-28 Diadexus, Inc. Compositions et methodes concernant des genes et des proteines specifiques de la prostate
WO2002036808A2 (fr) * 2000-11-03 2002-05-10 Diadexus, Inc. Compositions et methodes relatives a des genes et des proteines specifiques de la prostate
US20030064377A1 (en) * 2000-11-06 2003-04-03 Yongming Sun Compositions and methods relating to prostate specific genes and proteins
AU2002217991A1 (en) * 2000-11-21 2002-06-03 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
WO2002042329A2 (fr) * 2000-11-21 2002-05-30 Diadexus, Inc. Compositions et methodes se rapportant a des genes prostatiques specifiques et a des proteines
US20060040882A1 (en) * 2004-05-04 2006-02-23 Lishan Chen Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
US8309222B2 (en) * 2007-04-25 2012-11-13 Covidien Lp Coated filaments
DK2591114T3 (en) 2010-07-06 2016-08-29 Glaxosmithkline Biologicals Sa Immunization of large mammals with low doses of RNA
LT3243526T (lt) 2010-07-06 2020-02-10 Glaxosmithkline Biologicals S.A. Rnr pristatymas, skirtas keleto imuninio atsako paleidimui
WO2012006378A1 (fr) 2010-07-06 2012-01-12 Novartis Ag Liposomes à lipides ayant une valeur de pka avantageuse pour la délivrance d'arn
SI4005592T1 (sl) 2010-07-06 2023-03-31 Glaxosmithkline Biologicals S.A. Virionom podobni dostavni delci za samopodvojene molekule RNA
DK2611461T3 (da) 2010-08-31 2022-05-16 Glaxosmithkline Biologicals Sa Pegylerede liposomer til afgivelse af RNA, der koder immunogen
WO2012051211A2 (fr) 2010-10-11 2012-04-19 Novartis Ag Plateformes de délivrance d'antigènes
ES2656050T3 (es) 2011-07-06 2018-02-22 Glaxosmithkline Biologicals Sa Composiciones de combinación inmunogénica y usos de las mismas
WO2015088286A1 (fr) * 2013-12-12 2015-06-18 사회복지법인 삼성생명공익재단 Composition pharmaceutique pour traiter des maladies cérébrovasculaires, contenant un exosome dérivé de cellules souches en tant que substance active
JP2018518463A (ja) * 2015-04-30 2018-07-12 ヒストジェン インコーポレイテッド 癌または免疫疾患の治療のための細胞外マトリックス組成物

Also Published As

Publication number Publication date
US20020106780A1 (en) 2002-08-08
JP2004504011A (ja) 2004-02-12
EP1287015A1 (fr) 2003-03-05
CA2403508A1 (fr) 2001-10-25
WO2001079253A1 (fr) 2001-10-25

Similar Documents

Publication Publication Date Title
AU2001271714A1 (en) B7-like polynucleotides, polypeptides, and antibodies
AU2001233156A1 (en) Bcl-2-like polynucleotides, polypeptides, and antibodies
AU2413401A (en) Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use
AU2001253323A1 (en) Extracellular matrix polynucleotides, polypeptides, and antibodies
AU3075801A (en) Transferrin polynucleotides, polypeptides, and antibodies
AU1191001A (en) Plasminogen-like polynucleotides, polypeptides, and antibodies
AU7337400A (en) B7-like polynucleotides, polypeptides, and antibodies
AUPQ976800A0 (en) Novel polypeptides and polynucleotides and uses therefor
AU1582401A (en) Uteroglobin-like polynucleotides, polypeptides, and antibodies
AU7335400A (en) Attractin-like polynucleotides, polypeptides, and antibodies
AU7330400A (en) Retinoid receptor interacting polynucleotides, polypeptides, and antibodies
AU2001238585A1 (en) Human polynucleotides, polypeptides, and antibodies
AU7056100A (en) Tgf-beta receptor polynucleotides, polypeptides, and antibodies
AU2001241611A1 (en) Adam polynucleotides, polypeptides, and antibodies
AU4001000A (en) Dwf4 polynucleotides, polypeptides and uses thereof
AU2590201A (en) Trefoil domain-containing polynucleotides, polypeptides, and antibodies
AU2001241610A1 (en) Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
AU4273099A (en) Polypeptides, polynucleotides and uses thereof
AU2002351469A1 (en) Acrp30-like polynucleotides, polypeptides, and antibodies
AU5491599A (en) Irak3 polypeptides, polynucleotides and methods
AU1571299A (en) Polypeptides, polynucleotides and uses thereof
AU2001229517A1 (en) Human polynucleotides, polypeptides, and antibodies
EP1212415A4 (fr) Anticorps, polypeptides et polynucleotides pgrp-l
AU2001247306A1 (en) Immune system-related polynucleotides, polypeptides, and antibodies
IL161234A0 (en) Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof